ArticleCurrent microbiology2025
Levilactobacillus brevis MW362790 and Pediococcus pentosaceus MT323062 Alleviate Cadmium-Induced Oxidative Stress and Hepato-renal Toxicity.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combatting Cadmium Toxicity in Animals with Nature-Derived Remedies: Mechanisms and Mitigation.Biological trace element research · 2026Review
- The therapeutic potential ofFrontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heavy metal contamination, particularly cadmium (Cd), poses serious health risks through bioaccumulation and oxidative stress. Certain lactic acid bacteria (LAB) exhibit metal-binding properties and have demonstrated potential in mitigating Cd toxicity. This study evaluated the ameliorative effects of two locally isolated LAB strains Levilactobacillus brevis MW362790 and Pediococcus pentosaceus MT323062 against Cd-induced toxicity in rat model. Over 12 weeks of experiment, rats were divided into four groups (I-IV): a negative control, a CdCl₂-intoxicated positive control (3 mg/kg body weight), and two treatment groups receiving CdCl₂ along with either L. brevis or P. pentosaceus (5 × 10⁹ CFU/kg body weight), respectively. Blood samples were collected fortnightly, while liver, kidney, adipose tissue, and fecal samples were collected at the end of the experiment. Compared to the positive control, both probiotic-treated groups (III and IV) displayed significantly reduced Cd accumulation in tissues, improved levels of hepatic and renal function markers, decreased malondialdehyde and total oxidative stress markers, and enhanced enzymatic antioxidant activities. Histopathological evaluations further corroborated these findings, by revealing reduced tissue damage in treated animals. Moreover, the increased fecal Cd excretion in the same groups indicated effective intestinal Cd elimination. This is the first report demonstrating Cd-attenuating potential of L. brevis MW362790, underscoring the therapeutic significance of locally isolated LAB strains in managing heavy metal toxicity.
Indexed as
Identifiers
40844622What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.